Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | SHFS 0.1324 -61.39% | XXII 0.1977 -8.34% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | RBNE 0.19 -2.56% | YFOR 0.2236 -1.58% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | TQQQ 66.29 -0.20% | TSLL 9.76 -1.21% | VZ 44.66 -1.19% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | GRAB 2.79 -2.11% | AIOK 12.02 182.82% | SQQQ 39.68 0.20% | ONDS 6.2 2.99% | LABT 0.31 -36.67% | AAPL 347.725 -0.14% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | IREN 24.905 -2.37% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | NFLX 65.85 -1.79% | QID 14.55 0.14% | CLRO 3.25 69.27% | WULF 11.32 0.00%
AGApplied Genetic Technologies Corporation logo

Applied Genetic Technologies Corporation (AGTC)

NASDAQ Global Market · Currency in USD
$0.39 ▲ +0.00 (+0.00%)
At close: Nov 30, 4:00 PM ET. Market closed.

Summary

Previous Close
$0.39
Open
$0.37
Day's Range
$0.37 – $0.40
52 Week Range
$0.23 – $2.83
Volume
764,531
Avg. Volume
1,278,449
Market Cap
$0
Beta (5Y Monthly)
1.58
PE Ratio (TTM)
--
EPS (TTM)
-$1.59
Earnings Date
--
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
--

Profile: Applied Genetic Technologies Corporation

Sector
Healthcare
Industry
Biotechnology
Full-time employees
102
CEO
Susan Washer

Applied Genetic Technologies Corporation (AGTC) is a clinical-stage biotechnology company focused on developing innovative genetic therapies aimed at transforming the lives of patients battling rare and debilitating diseases. Its advanced product portfolio includes three ophthalmology development programs addressing two specific targets. These encompass treatments for X-linked retinitis pigmentosa and achromatopsia, both currently undergoing Phase 1/2 clinical trials.

Earnings

DateEst.Actual
Nov 21, 2022-$0.28-$0.28Beat
Sep 27, 2022-$0.34-$0.36Miss
May 16, 2022-$0.43-$0.33Beat
Feb 14, 2022-$0.38-$0.45Miss
Nov 9, 2021-$0.35-$0.40Miss
Sep 23, 2021-$0.40-$0.28Beat

Analyst view

Rating: Buy
Buy 64% · Hold 36% · Sell -0%

Get free alerts on AGTC and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.